Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
INTS: Intensity Therapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
INTS
The Story
INTS
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-110.1%
Financially safe
Stretched
Debt / equity
0.01×
Interest coverage
0.0×
Current ratio
4.86×
Intensity Therapeutics, Inc.
INTS
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Intensity Therapeutics, Inc.
INTS
NASDAQ
·
USD
·
Closed
$4.15
+2.47%
$4.15
+$0.10 (2.47%)
52W Range
2th
pctl
Volume
1.94×
avg
Mkt Cap
11.22M
USD
P/E
-0.6
TTM
Div Yield
–
ann
52W Range
2th
pctl
Volume
1.94×
avg
Market Cap
11.22M
USD
P/E Ratio
-0.6
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings